Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CV Sciences (CVSI) EPS (Weighted Average and Diluted) (2017 - 2025)

CV Sciences' EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.01 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 225.42% to -$0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.01, a 555.17% decrease, with the full-year FY2025 number at -$0.01, changed 0.0% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.01 in Q4 2025 for CV Sciences, down from -$0.0 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CVSI hit a ceiling of $0.04 in Q1 2023 and a floor of -$0.08 in Q4 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.01 across 5 years, with a median of -$0.01 in 2024.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 2627.88% in 2022 and later soared 300.0% in 2023.
  • Tracing CVSI's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.08 in 2021, then soared by 75.0% to -$0.02 in 2022, then skyrocketed by 50.0% to -$0.01 in 2023, then surged by 179.73% to $0.01 in 2024, then plummeted by 225.42% to -$0.01 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CVSI at -$0.01 in Q4 2025, -$0.0 in Q3 2025, and -$0.0 in Q2 2025.